PharmaTimesNews & Politicsnews

Cenrifki approved in EU for secondary progressive multiple sclerosis

Tuesday, June 23, 2026John PinchingView original

Sanofi therapy becomes first disability‑targeting medicine for nrSPMS

Read the full article on the original site.

Read Full Article